Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/33151
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Horowitz, M. | - |
dc.contributor.author | Feinle-Bisset, C. | - |
dc.contributor.author | Jones, K. | - |
dc.contributor.author | Nauck, M. | - |
dc.date.issued | 2004 | - |
dc.identifier.citation | Diabetes Care, 2004; 27(11):2770-2770 | - |
dc.identifier.issn | 0149-5992 | - |
dc.identifier.issn | 1935-5548 | - |
dc.identifier.uri | http://hdl.handle.net/2440/33151 | - |
dc.description | © 2004 by the American Diabetes Association, Inc. | - |
dc.description.statementofresponsibility | Michael Horowitz, Christine Feinle-Bisset, Karen Jones and Michael Nauck | - |
dc.language.iso | en | - |
dc.publisher | Amer Diabetes Assoc | - |
dc.source.uri | http://dx.doi.org/10.2337/diacare.27.11.2770 | - |
dc.subject | Humans | - |
dc.subject | Diabetes Mellitus, Type 2 | - |
dc.subject | Obesity | - |
dc.subject | Lactones | - |
dc.subject | Glucagon | - |
dc.subject | Peptide Fragments | - |
dc.subject | Protein Precursors | - |
dc.subject | Anti-Obesity Agents | - |
dc.subject | Postprandial Period | - |
dc.subject | Glucagon-Like Peptide 1 | - |
dc.subject | Orlistat | - |
dc.title | Orlistat augments postprandial increases in glucagon-like peptide-1 in obese type 2 diabetic patients - Response to Damci et al. | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.2337/diacare.27.11.2770 | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Horowitz, M. [0000-0002-0942-0306] | - |
dc.identifier.orcid | Feinle-Bisset, C. [0000-0001-6848-0125] | - |
dc.identifier.orcid | Jones, K. [0000-0002-1155-5816] | - |
Appears in Collections: | Aurora harvest Medicine publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.